Zengin Seniyye Ulgen, Saracoglu Ayten, Eti Zeynep, Umuroglu Tumay, Gogus Fevzi Yilmaz
Pain Res Manag. 2015 Jul-Aug;20(4):179-82. doi: 10.1155/2015/509474. Epub 2015 May 7.
To evaluate and compare the effects of preoperative oral pregabalin and perioperative intravenous lidocaine infusion on postoperative morphine requirement, adverse effects, patients' satisfaction, mobilization, time to first defecation and time to discharge in patients undergoing laparotomy.
Eighty patients (18 to 65 years of age) undergoing elective laparotomy were randomly divided into four groups (n=20 in each group): group C, placebo capsules and normal saline infusion perioperatively (control); group L, placebo capsules and lidocaine 1 mg⁄kg intravenous bolus dose followed by 2 mg⁄kg⁄h infusion until skin closure; group P, 150 mg oral pregabalin and normal saline infusion perioperatively; and group PL, 150 mg oral pregabalin and lidocaine 2 mg⁄kg⁄h infusion until skin closure. Hemodynamic parameters, visual analogue scale (VAS) scores, analgesic consumption, side effects, time to mobilization, time to first defecation, time to discharge and patients' satisfaction were recorded.
VAS scores of group L, group P and group PL were lower than group C (P<0.05). Morphine consumption of group P and group PL was lower than group C (P<0.05). Incidence of nausea in group C was higher than group L and group PL. Time to first defecation and mobilization were shorter in group L and group PL compared with group C (P<0.05).
Preoperative oral pregabalin and perioperative intravenous lidocaine infusion decreased postoperative VAS scores. Preoperative oral pregabalin decreased morphine requirement and perioperative intravenous lidocaine infusion hastened gastrointestinal motility and mobilization, and decreased the incidence of nausea in patients undergoing laparotomy. Therefore, preoperative pregabalin with or without lidocaine provides superior pain relief in patients undergoing laparatomy.
评估并比较术前口服普瑞巴林和围手术期静脉输注利多卡因对剖腹手术患者术后吗啡需求量、不良反应、患者满意度、活动能力、首次排便时间和出院时间的影响。
80例择期行剖腹手术的患者(年龄18至65岁)被随机分为四组(每组n = 20):C组,围手术期服用安慰剂胶囊并输注生理盐水(对照组);L组,服用安慰剂胶囊,静脉注射1 mg/kg利多卡因推注剂量,随后以2 mg/kg/h输注直至皮肤缝合;P组,术前口服150 mg普瑞巴林并围手术期输注生理盐水;PL组,术前口服150 mg普瑞巴林并以2 mg/kg/h输注利多卡因直至皮肤缝合。记录血流动力学参数、视觉模拟评分(VAS)、镇痛药物用量、副作用、活动时间、首次排便时间、出院时间和患者满意度。
L组、P组和PL组的VAS评分低于C组(P<0.05)。P组和PL组的吗啡用量低于C组(P<0.05)。C组恶心发生率高于L组和PL组。与C组相比,L组和PL组的首次排便时间和活动时间更短(P<0.05)。
术前口服普瑞巴林和围手术期静脉输注利多卡因可降低术后VAS评分。术前口服普瑞巴林可降低吗啡需求量,围手术期静脉输注利多卡因可促进胃肠蠕动和活动能力,并降低剖腹手术患者的恶心发生率。因此,术前使用普瑞巴林联合或不联合利多卡因可为剖腹手术患者提供更好的疼痛缓解效果。